Hikma Pharmaceuticals Plc (OTCMKTS:HKMPF – Get Free Report) shares fell 1.2% during mid-day trading on Monday . The stock traded as low as $22.16 and last traded at $22.16. 2,540 shares were traded during trading, an increase of 112% from the average session volume of 1,198 shares. The stock had previously closed at $22.42.
Hikma Pharmaceuticals Stock Down 1.2%
The firm’s 50 day simple moving average is $25.59 and its 200-day simple moving average is $26.47. The company has a debt-to-equity ratio of 0.33, a quick ratio of 0.72 and a current ratio of 1.24.
About Hikma Pharmaceuticals
Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment provides generic injectable products primarily for use in hospitals.
Featured Stories
- Five stocks we like better than Hikma Pharmaceuticals
- Want to Profit on the Downtrend? Downtrends, Explained.
- Reddit Hits Record Highs: Why Wall Street Is Taking Notice
- Most active stocks: Dollar volume vs share volume
- After a Strong Wall Street Debut, Klarna’s Real Work Begins
- Why Invest in High-Yield Dividend Stocks?
- 3 Dividend Growers That Fly Under the Radar
Receive News & Ratings for Hikma Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hikma Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
